YP1B Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Immutep Ltd

Watchlist Manager

Watchlist

Price: 0.021 EUR -4.55% Market Closed

Market Cap: €30.5m

I	Immutep Ltd F:YP1B	AU
	Kiniksa Pharmaceuticals Ltd NASDAQ:KNSA	BM
A	Abacus Mining and Exploration Corp OTC:ABCFF	CA
V	Vow ASA F:213	NO
	Shofu Inc TSE:7979	JP
S	Sula Vineyards Ltd BSE:543711	IN
V	Volvo AB XMUN:VOL1	SE
V	Volkswagen AG XMUN:VOW3	DE
	De La Rue PLC LSE:DLAR	UK
P	Pharol SGPS SA DUS:PTCA	PT

Profitability Summary

Immutep Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-2 154%

Negative 3Y Average Operating Margin

-51 037%

Operating Margin is Increasing

-25 143% > -2 154%

Negative Net Margin

-2 031%

Negative 3Y Average Net Margin

-42 973%

Net Margin is Increasing

-20 812% > -2 031%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-42 310%

Free Cash Flow Margin is Increasing

-18 486% > 1%

Negative ROE

-62%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-329%

ROIC is Increasing

-311% > -306%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.